KJ Baby - Big Opportunity for Bionano Genomics
Post# of 58

With the world watching KJ’s treatment, Bionano could step in and showcase how OGM enhances gene therapy safety. By offering OGM for structural validation and monitoring, they could help establish best practices for genomic stability checks after gene editing—a crucial aspect of future treatments.
OGM could become a standard tool in gene therapy, ensuring that treatments like KJ’s remain safe and effective for years to come.

